IDXG   $2.66  -0.75% Market Closed

Interpace Biosciences Inc
Total Cash 2.11M
totalCashPerShare 0.481
EBITDA 6.63M
Total Debt 0.00
quickRatio 0.113
currentRatio 0.592
Total Revenue 44.89M
debtToEquity
Revenue/Share 10.279
ROA 0.28085
ROE
grossProfits
freeCashflow 9.55M
operatingCashflow 4.60M
earningsGrowth
revenueGrowth 0.354
grossMargins 0.60464
ebitdaMargins 0.14766
operatingMargins 0.15494001
profitMargins 0.10469
enterpriseValue 10.60M
forwardPE
floatShares 3.36M
sharesOutstanding 4.40M
sharesShort 47.35K
sharesShortPriorMonth 68.56K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.26%
heldPercentInstitutions 0.0
Short Ratio help_outline 0.19%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue -13.13
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon 4.88M
trailingEps 0.66%
forwardEps -0.15%
enterpriseToEbitda 1.60
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2022
institutionsCount 0
lastUpdated Nov. 7, 2024, 4:56 a.m.